A Review of Primary. Secondary, and Tertiary Prevention Strategies for Alzheimer’s Disease

Author:

O'Donnell Heather1

Affiliation:

1. Rutgers University

Abstract

This paper explores the non-modifiable and modifiable risk factors for Alzheimer’s, as well as the Alzheimer’s primary prevention, secondary prevention, and tertiary prevention strategies that can be implemented. Alzheimer's is the sixth leading cause of death in the United States and the most expensive chronic disease (Alzheimer’s Association, 2020). It has a detrimental physical, psychological, and financial impact on patients and caregivers (Alzheimer’s Association, 2020). People can reduce their risk of developing Alzheimer’s by eating a healthy diet, using hearing aids for hearing loss, engaging in regular physical activity, spending time with other people, doing mentally stimulating activities, reducing alcohol consumption, and avoiding tobacco (Livingston et al., 2020). Early screening and diagnostic tools are important because they allow people living with Alzheimer’s to establish an effective care plan and to take advantage of treatments, which are most effective in the early stages of the disease (Guzman-Martinez et al., 2021). Some screening and diagnostic tools include biomarkers, scalable screening technologies, and cognitive assessments (Guzman-Martinez et al.,18 2021). Primary and secondary prevention strategies must address the needs of minority populations, who have a higher risk of developing Alzheimer’s compared to the general population (Livingston et al., 2020). Federal public health initiatives, such as the National Alzheimer’s Project Act, the Dementia Prevention Action Plan, and the Behavioral Risk Surveillance System, play an important role in Alzheimer’s public health research, surveillance, and prevention strategies (Chong et al., 2021; Kelley et al., 2018).

Publisher

University of Michigan Library

Subject

General Medicine

Reference34 articles.

1. 2020 Alzheimer’s disease facts and figures. (2020). Alzheimer’s & Dementia, 16(3), 391–460. https://doi.org/10.1002/alz.12068. https://alz journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12068.

2. Age-adjusted death rates for selected causes of death, by sex, race, and Hispanic origin: United States, selected years 1950–2018. (2019). Centers for disease control and prevention national center for health statistics, health, United States. https://www.cdc.gov/nchs/data/hus/2019/005-508.pdf

3. Breijyeh, Z., & Karaman, R. (2020). Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules (Basel, Switzerland), 25(24), 5789. https://doi.org/10.3390/molecules25245789. https://www.proquest.com/naturalscience/docview/2469692243/CBB99D304E3A4D7AP Q/17.

4. Dementia prevention: The time to act is now;Chong, T. W.Macpherson, H.Schaumberg, M. A.Brown, B. M.Naismith, S. L.Steiner, G. Z.;Medical Journal of Australia,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3